Connection

Silvio Danese to Anti-Inflammatory Agents

Back to Details
This is a "connection" page, showing publications Silvio Danese has written about Anti-Inflammatory Agents.
Silvio Danese
Connection Strength
0.878
Anti-Inflammatory Agents
  1. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease. Gastroenterology. 2019 10; 157(4):1007-1018.e7.
    View in: PubMed
    Score: 0.202
  2. Novel therapeutic targets for inflammatory bowel disease. J Autoimmun. 2017 Dec; 85:103-116.
    View in: PubMed
    Score: 0.176
  3. Disease-related and drug-induced skin manifestations in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2017 Mar; 11(3):203-214.
    View in: PubMed
    Score: 0.171
  4. IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy. Expert Rev Clin Immunol. 2017 05; 13(5):457-467.
    View in: PubMed
    Score: 0.170
  5. Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic. J Crohns Colitis. 2020 Oct 21; 14(14 Suppl 3):S815-S819.
    View in: PubMed
    Score: 0.055
  6. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2019 09 26; 381(13):1201-1214.
    View in: PubMed
    Score: 0.051
  7. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. N Engl J Med. 2019 09 26; 381(13):1215-1226.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.